Philips and Italian Fatebenefratelli Hospital Sign Multiyear Strategic Partnership to Enable Family-Centered Care for Mother and Child

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the historic San Giovanni Calibita Fatebenefratelli Hospital in Rome today announced a long-term strategic partnership to introduce state-of-the-art Family Centered Care (FCC) at the hospital. This 6-year collaboration will enable the San Giovanni Calibita to deliver developmentally focused, family centered mother-and-child care of the highest clinical quality.

The partnership, with the development of a new Neonatal Intensive Care Unit (NICU) at its core, aims at providing a safe, warm, intimate and supportive environment that accommodates ongoing family contact and reduces neonatal stress. Philips will be responsible for providing a full suite of technologies and services comprising medical equipment and accompanying maintenance, clinical informatics, innovation, training and tailored financing solutions. Philips will implement a centralized command system that works with advanced patient monitoring equipment in the NICU room to enable continuous surveillance of the neonates and monitoring of their vital signs.

The partnership between Philips and San Giovanni Calibita will strengthen the hospital’s expertise in providing mother-and-child care: today it supports the birth of 4,000 newborns and provides critical medical care for 400 premature babies each year, not only from the Lazio Region, but also from the whole of Italy.

"Dealing with the growing need for care and ever challenging budget constraints, hospitals are looking for an increased level of innovation and commitment from health technology companies like Philips," said Stefano Folli, CEO and President of Philips Italy, Israel and Greece. "We are proud to introduce a very innovative strategic collaboration model in Italy with a forward-looking institution like the San Giovanni Calibita Fatebenefratelli Hospital, thus settling a new co-creation paradigm in the healthcare industry that is leading today our business strategy."

"This is a next step forward in the renewal and revitalization of the hospital to ensure long-term excellence and innovation to citizens, always respecting our founding values," comments Dario Gaeta, Managing Director of the San Giovanni Calibita Fatebenefratelli Hospital. "Working with Philips allows us to co-create a sustainable integral solution that combines efficiency with the best possible clinical care and the sensitivity of the human touch that is needed in a NICU. This agreement is the latest in time of other partnerships the Hospital signed and is studying with other strategic partners."

The renovation and modernization work in the San Giovanni Calibita Fatebenefratelli Hospital will end in Autumn 2017. Meanwhile, the Neonatal Intensive Care Unit, which is already open to parents 24 hours a day, continues to provide high levels of care and services built around the needs of newborns and their families.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries.

About Hospital San Giovanni Calibita Fatebenefratelli
San Giovanni Calibita - Fatebenefratelli Hospital of Tiberina Island in Rome was founded in 1584. As General Hospital of the area since 1972, it is equated with public health centers, while preserving the private nature of the institution and administration owned by the Religious Hospitaller Order of Saint John of God "Fatebenefratelli". Over the years, the Hospital has experienced a constant evolution and a persistent adaptation to the needs of the territory to continue to be a reference point and a model in the area where the Fatebenefratelli religious brothers have been operating for over 500 years. Today, the Health Care Center is divided into more than twenty Departments serving all citizens from the Region and above. Several points of excellence developed over the years. Particularly, the Hospital, with about 4000 births a year, is an important reference point for maternal-fetal medicine in the area as well as the rest of Italy. Especially, women who have pathology in pregnancy (30%) are ensured access to an Intensive Care Service for Mother and Child. The Neonatal Intensive Care of the Hospital annually receives about 600 children, 400 of them are premature and subjected to periodic checks even after their discharge, for a period of 5 years, with the maximum collaboration between the various divisions of the Hospital.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...